Finance Committee Chairman Sen. Max Baucus (D., Mont.).


September 15, 2009 - The Finance Committee in a health-overhaul bill calls for device makers to pay $40 billion in fees over 10 years, with the specific amount based on each company's market share.

Meanwhile, medical-device manufacturers are rushing to reverse billions of dollars in fees proposed by the Senate Finance Committee. The fees resulted from a lobbying move where medical device-makers went to the White House this spring to volunteer financial concessions as part of an overhaul where they were asked to provide a financial figures in savings. The companies suggested that instead the government should tax hospital-purchasing groups (GPOs) that negotiate for lower prices on medical supplies and some devices. This way, they reasoned, the GPOs would pass on some or all of that tax to the device makers.

Finance Committee Chairman Sen. Max Baucus (D., Mont.), plans to make public his bill today, and the new fees on device makers' revenues are expected to be part of the new law. According to the bill, all manufacturers would be assessed at a rate based upon their U.S. sales to generate $4 billion annually beginning in 2010.

Some say the government believes device makers will greatly benefit from an overhaul because wider insurance coverage will bring them more customers, and the White House wants savings commitments to help pay for the package.


Related Content

News | Radiopharmaceuticals and Tracers

Oct. 19, 2026 — Nuclidium AG, a clinical-stage radiopharmaceutical company, and NorthStar Medical Technologies, a global ...

Time October 19, 2026
arrow
News | Molecular Imaging

Editor's Note: This article has been updated to correct an earlier version. Oct. 15, 2026 — GE HealthCare has announced ...

Time October 16, 2026
arrow
News | Information Technology

October 6, 2026 – Clearsense has introduced a cloud-based medical image archive designed to reduce the cost of ...

Time October 07, 2026
arrow
News | Radiopharmaceuticals and Tracers

Oct. 5, 2026 — GE HealthCare has announced a definitive agreement to acquire SOFIE Biosciences, a U.S.-based CMO for PET ...

Time October 06, 2026
arrow
News | PET-MRI

Sept. 29, 2026 —Yale New Haven Hospital has installed a state-of-the-art positron emission tomography/magnetic resonance ...

Time October 05, 2026
arrow
News | Radiopharmaceuticals and Tracers

Aug. 30, 2026 — Bayer has announced the presentation of first detailed results from the Phase III REVEAL study, an ...

Time September 02, 2026
arrow
News | PET-MRI

June 10, 2026 — UTHealth Houston has launched a state-of-the-art PET/MRI imaging service, bringing together two advanced ...

Time June 12, 2026
arrow
News | Nuclear Imaging

June 1, 2026 — At the 2026 Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting, GE HealthCare will ...

Time June 02, 2026
arrow
News | Radiopharmaceuticals and Tracers

May 27, 2026 — Subtle Medical has received FDA clearance for its SubtleHD (PET), the company's next-generation AI ...

Time May 27, 2026
arrow
News | Radiopharmaceuticals and Tracers

May 7, 2026 — Bayer has announced positive topline results from the Phase III REVEAL study, an investigator-initiated ...

Time May 08, 2026
arrow
Subscribe Now